Search research articles
Contact Us
Filters
Showing results (41-50 of 46) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 46 results.
Cell Reports
|
April 27, 2022
Structures of Omicron spike complexes and implications for neutralizing antibody development
Hangtian Guo, Yan Gao, Tinghan Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 26, 2026
First-Line Disitamab Vedotin, Tislelizumab, and S-1 in HER2-Overexpressing Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: A Single-Arm, Phase II Trial
Song Li, Zimin Liu, Yanguo Liu, et al.
JCI Insight
|
April 8, 2024
Prophylactic efficacy of an intranasal spray with 2 synergetic antibodies neutralizing Omicron
Xinghai Zhang, Feiyang Luo, Huajun Zhang, et al.
Frontiers in Immunology
|
April 8, 2021
A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2
Xiaojian Han, Yingming Wang, Shenglong Li, et al.
Nature Communications
|
November 3, 2021
Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
Tingting Li, Xiaojian Han, Chenjian Gu, et al.
Cell Reports
|
January 22, 2023
Bivalent intra-spike binding provides durability against emergent Omicron lineages: Results from a global consortium
Heather M Callaway, Kathryn M Hastie, Sharon L Schendel, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 46) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 46 results.
Cell Reports
|
April 27, 2022
Structures of Omicron spike complexes and implications for neutralizing antibody development
Hangtian Guo, Yan Gao, Tinghan Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 26, 2026
First-Line Disitamab Vedotin, Tislelizumab, and S-1 in HER2-Overexpressing Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: A Single-Arm, Phase II Trial
Song Li, Zimin Liu, Yanguo Liu, et al.
JCI Insight
|
April 8, 2024
Prophylactic efficacy of an intranasal spray with 2 synergetic antibodies neutralizing Omicron
Xinghai Zhang, Feiyang Luo, Huajun Zhang, et al.
Frontiers in Immunology
|
April 8, 2021
A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2
Xiaojian Han, Yingming Wang, Shenglong Li, et al.
Nature Communications
|
November 3, 2021
Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
Tingting Li, Xiaojian Han, Chenjian Gu, et al.
Cell Reports
|
January 22, 2023
Bivalent intra-spike binding provides durability against emergent Omicron lineages: Results from a global consortium
Heather M Callaway, Kathryn M Hastie, Sharon L Schendel, et al.
Page
of 5